Meghmani Organics Limited Logo

Meghmani Organics Limited

MEGH.NS

(1.8)
Stock Price

139,00 INR

0% ROA

23.79% ROE

37.45x PER

Market Cap.

35.285.704.610,00 INR

0% DER

0% Yield

4.29% NPM

Meghmani Organics Limited Stock Analysis

Meghmani Organics Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Meghmani Organics Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (23.79%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (0x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

4 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (2.114) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

5 ROA

The stock's ROA (0%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

Meghmani Organics Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Meghmani Organics Limited Technical Stock Analysis
# Analysis Recommendation

Meghmani Organics Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Meghmani Organics Limited Revenue
Year Revenue Growth
2002 2.024.034.000
2003 2.440.319.000 17.06%
2004 3.366.227.000 27.51%
2005 3.878.943.000 13.22%
2006 4.680.924.000 17.13%
2007 5.973.513.332 21.64%
2008 7.914.002.081 24.52%
2009 8.162.723.553 3.05%
2010 10.246.738.378 20.34%
2011 10.625.425.736 3.56%
2012 7.602.273.228 -39.77%
2013 11.844.622.932 35.82%
2014 12.942.073.328 8.48%
2015 13.559.366.480 4.55%
2016 15.462.767.000 12.31%
2017 17.993.748.000 14.07%
2018 20.863.743.000 13.76%
2019 21.883.743.000 4.66%
2020 16.366.561.000 -33.71%
2021 24.984.581.000 34.49%
2022 25.526.243.000 2.12%
2023 17.031.088.000 -49.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Meghmani Organics Limited Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 10.969.523 100%
2015 13.880.427 20.97%
2016 0 0%
2017 19.129.000 100%
2018 1.738.000 -1000.63%
2019 24.811.000 93%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Meghmani Organics Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 78.826.000
2003 92.163.000 14.47%
2004 351.712.000 73.8%
2005 483.874.000 27.31%
2006 562.928.000 14.04%
2007 140.470.512 -300.74%
2008 356.885.699 60.64%
2009 201.115.860 -77.45%
2010 1.135.833.985 82.29%
2011 0 0%
2012 0 0%
2013 0 0%
2014 47.095.770 100%
2015 326.975.772 85.6%
2016 0 0%
2017 101.158.000 100%
2018 92.345.000 -9.54%
2019 129.731.000 28.82%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Meghmani Organics Limited EBITDA
Year EBITDA Growth
2002 211.783.000
2003 366.029.000 42.14%
2004 502.998.000 27.23%
2005 582.736.000 13.68%
2006 544.308.000 -7.06%
2007 554.538.331 1.84%
2008 917.224.732 39.54%
2009 1.415.226.010 35.19%
2010 1.607.226.997 11.95%
2011 1.687.467.454 4.76%
2012 2.341.147.650 27.92%
2013 4.325.625.495 45.88%
2014 2.235.117.249 -93.53%
2015 2.964.432.132 24.6%
2016 2.973.739.000 0.31%
2017 4.669.742.000 36.32%
2018 5.755.149.000 18.86%
2019 4.966.240.000 -15.89%
2020 2.813.678.000 -76.5%
2021 3.770.782.000 25.38%
2022 3.387.816.000 -11.3%
2023 -1.084.005.000 412.53%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Meghmani Organics Limited Gross Profit
Year Gross Profit Growth
2002 597.367.000
2003 647.166.000 7.69%
2004 728.368.000 11.15%
2005 972.735.000 25.12%
2006 1.096.831.000 11.31%
2007 1.468.993.234 25.33%
2008 2.018.851.545 27.24%
2009 1.999.751.847 -0.96%
2010 3.506.077.683 42.96%
2011 4.926.689.953 28.84%
2012 2.739.355.120 -79.85%
2013 4.931.369.864 44.45%
2014 3.424.434.359 -44.01%
2015 4.422.390.971 22.57%
2016 7.523.120.000 41.22%
2017 8.311.153.000 9.48%
2018 9.955.251.000 16.51%
2019 8.854.071.000 -12.44%
2020 7.173.868.000 -23.42%
2021 10.230.705.000 29.88%
2022 10.168.141.000 -0.62%
2023 4.661.180.000 -118.15%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Meghmani Organics Limited Net Profit
Year Net Profit Growth
2002 216.507.000
2003 294.996.000 26.61%
2004 302.013.000 2.32%
2005 366.690.000 17.64%
2006 414.875.000 11.61%
2007 306.122.269 -35.53%
2008 371.213.989 17.53%
2009 516.762.334 28.17%
2010 380.064.142 -35.97%
2011 34.838.468 -990.93%
2012 57.824.873 39.75%
2013 228.041.806 74.64%
2014 438.896.096 48.04%
2015 825.764.165 46.85%
2016 877.038.000 5.85%
2017 1.713.218.000 48.81%
2018 2.512.725.000 31.82%
2019 2.401.464.000 -4.63%
2020 1.864.761.000 -28.78%
2021 3.044.208.000 38.74%
2022 2.377.082.000 -28.06%
2023 -1.379.972.000 272.26%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Meghmani Organics Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 1
2003 1 100%
2004 1 0%
2005 1 0%
2006 2 0%
2007 1 0%
2008 1 0%
2009 2 50%
2010 1 -100%
2011 0 0%
2012 0 0%
2013 1 0%
2014 2 100%
2015 3 66.67%
2016 3 0%
2017 7 50%
2018 10 33.33%
2019 9 0%
2020 7 -28.57%
2021 12 36.36%
2022 9 -22.22%
2023 -5 280%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Meghmani Organics Limited Free Cashflow
Year Free Cashflow Growth
2002 18.991.000
2003 -213.944.000 108.88%
2004 -192.083.000 -11.38%
2005 -408.718.000 53%
2006 -303.155.000 -34.82%
2007 -1.036.128.395 70.74%
2008 -2.666.870.442 61.15%
2009 -681.056.430 -291.58%
2010 225.433.321 402.11%
2011 214.165.009 -5.26%
2012 35.150.201 -509.29%
2013 434.365.546 91.91%
2014 1.922.189.303 77.4%
2015 1.060.337.925 -81.28%
2016 1.878.582.000 43.56%
2017 1.592.696.000 -17.95%
2018 -30.973.000 5242.21%
2019 -867.384.000 96.43%
2020 1.240.067.000 169.95%
2021 -1.787.078.000 169.39%
2022 -2.606.744.000 31.44%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Meghmani Organics Limited Operating Cashflow
Year Operating Cashflow Growth
2002 209.757.000
2003 62.030.000 -238.15%
2004 5.289.000 -1072.81%
2005 -93.155.000 105.68%
2006 76.969.000 221.03%
2007 -562.446.465 113.68%
2008 546.645.229 202.89%
2009 737.325.824 25.86%
2010 1.259.815.135 41.47%
2011 1.301.679.022 3.22%
2012 682.465.138 -90.73%
2013 1.361.136.714 49.86%
2014 2.521.969.644 46.03%
2015 2.006.519.253 -25.69%
2016 2.588.337.000 22.48%
2017 4.048.906.000 36.07%
2018 3.748.892.000 -8%
2019 4.042.774.000 7.27%
2020 3.333.925.000 -21.26%
2021 648.322.000 -414.24%
2022 2.044.717.000 68.29%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Meghmani Organics Limited Capital Expenditure
Year Capital Expenditure Growth
2002 190.766.000
2003 275.974.000 30.88%
2004 197.372.000 -39.82%
2005 315.563.000 37.45%
2006 380.124.000 16.98%
2007 473.681.930 19.75%
2008 3.213.515.671 85.26%
2009 1.418.382.254 -126.56%
2010 1.034.381.814 -37.12%
2011 1.087.514.013 4.89%
2012 647.314.937 -68%
2013 926.771.168 30.15%
2014 599.780.341 -54.52%
2015 946.181.328 36.61%
2016 709.755.000 -33.31%
2017 2.456.210.000 71.1%
2018 3.779.865.000 35.02%
2019 4.910.158.000 23.02%
2020 2.093.858.000 -134.5%
2021 2.435.400.000 14.02%
2022 4.651.461.000 47.64%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Meghmani Organics Limited Equity
Year Equity Growth
2002 1.200.008.000
2003 1.453.822.000 17.46%
2004 2.179.479.000 33.29%
2005 2.478.114.000 12.05%
2006 2.812.920.000 11.9%
2007 4.403.910.188 36.13%
2008 5.083.169.911 13.36%
2009 5.354.782.900 5.07%
2010 5.542.367.158 3.38%
2011 5.327.475.392 -4.03%
2012 5.343.811.465 0.31%
2013 6.104.825.342 12.47%
2014 6.458.786.989 5.48%
2015 7.668.429.683 15.77%
2016 8.731.945.000 12.18%
2017 10.919.041.000 20.03%
2018 11.528.385.000 5.29%
2019 13.983.366.000 17.56%
2020 10.847.017.000 -28.91%
2021 13.539.994.000 19.89%
2022 15.572.786.000 13.05%
2023 0 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Meghmani Organics Limited Assets
Year Assets Growth
2002 2.173.042.000
2003 2.826.715.000 23.12%
2004 3.218.157.000 12.16%
2005 4.020.719.000 19.96%
2006 5.059.442.000 20.53%
2007 7.599.366.647 33.42%
2008 12.610.950.423 39.74%
2009 13.431.006.417 6.11%
2010 14.668.520.305 8.44%
2011 15.061.691.286 2.61%
2012 11.299.491.090 -33.3%
2013 16.634.876.848 32.07%
2014 15.444.348.750 -7.71%
2015 16.381.037.011 5.72%
2016 15.788.636.000 -3.75%
2017 18.184.130.000 13.17%
2018 23.767.584.000 23.49%
2019 27.369.208.000 13.16%
2020 19.741.508.000 -38.64%
2021 27.976.109.000 29.43%
2022 31.984.428.000 12.53%
2023 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Meghmani Organics Limited Liabilities
Year Liabilities Growth
2002 973.034.000
2003 1.372.893.000 29.13%
2004 1.038.678.000 -32.18%
2005 1.542.605.000 32.67%
2006 2.246.522.000 31.33%
2007 3.195.456.459 29.7%
2008 7.527.780.512 57.55%
2009 8.076.223.517 6.79%
2010 9.126.153.147 11.5%
2011 9.734.215.894 6.25%
2012 5.955.679.625 -63.44%
2013 10.530.051.506 43.44%
2014 8.985.561.761 -17.19%
2015 8.712.607.328 -3.13%
2016 7.056.691.000 -23.47%
2017 7.265.089.000 2.87%
2018 12.239.199.000 40.64%
2019 13.385.842.000 8.57%
2020 8.011.196.000 -67.09%
2021 13.313.865.000 39.83%
2022 15.292.153.000 12.94%
2023 0 0%

Meghmani Organics Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
86.53
Net Income per Share
3.71
Price to Earning Ratio
37.45x
Price To Sales Ratio
1.61x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0
EV to Sales
1.61
EV Over EBITDA
20.11
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.03
FreeCashFlow Yield
0
Market Cap
35,29 Bil.
Enterprise Value
35,29 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
3.71
Income Quality
0
ROE
0.24
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.74
EBT Per Ebit
1.22
Ebit per Revenue
0.05
Effective Tax Rate
0.4

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.36
Operating Profit Margin
0.05
Pretax Profit Margin
0.06
Net Profit Margin
0.04

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
1.88
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,61 Bil.
Invested Capital
0
Working Capital
0,61 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
2,24 Bil.
Average Inventory
3258633500
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Meghmani Organics Limited Dividends
Year Dividends Growth
2008 0
2009 0 0%
2010 1 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 1 100%
2020 1 0%

Meghmani Organics Limited Profile

About Meghmani Organics Limited

Meghmani Organics Limited engages in manufacturing and selling of pigment and agrochemicals products. The company operates through three segments: Agro Chemicals, Pigment Business, and Basic Chemicals. The Agro Chemicals segment provides technical, intermediates, and formulations of insecticides, fungicides, and herbicides, which are used in crop protection, public health, termite and insect control, and veterinary applications. The Pigment Business segment offers phthalocynine green 7, copper phthalocynine blue, alpha blue, and beta blue pigments that are used in various applications, including printing inks, plastics, paints, textiles, leather, paper, and rubber. The Basic Chemicals segment provides caustic chlorine and caustic potash, which are used by the agriculture sector, industry, and directly by the consumers. It is also involved in the trading of pigment and chemicals. The company primarily operates under the Megastar, Megacyper, Megaban, Synergy, Courage, Correct, and Mega Claim brand names. Meghmani Organics Limited offers its products to customers through direct sales teams and distributors/agents in North America, Europe, Central and Latin America, the Asia-Pacific, and internationally. The company was formerly known as Gujarat Industries. Meghmani Organics Limited was founded in 1986 and is based in Ahmedabad, India.

CEO
Mr. Ankit Patel
Employee
1.873
Address
Plot No: 183-84, Phase 2, G.I.D.C, Vatva
Ahmedabad,

Meghmani Organics Limited Executives & BODs

Meghmani Organics Limited Executives & BODs
# Name Age

Meghmani Organics Limited Competitors